Publicaciones en colaboración con investigadores/as de Hospital Universitario Araba (47)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Recommendations for the future management of thrombocytopenia in patients with liver cirrhosis: A modified RAND/UCLA appropriateness method

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 32-50

2023

  1. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  2. The implication of including Interventional Radiologists in multidisciplinary pulmonary embolism treatment teams

    Archivos de Bronconeumologia

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

  2. Kidney Support in Sepsis

    The Sepsis Codex (Elsevier), pp. 169-176

  3. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

  4. Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices

    International Journal of Bioprinting, Vol. 9, Núm. 2, pp. 219-255

2021

  1. Future scenarios and opportunities for interventional radiology in the post COVID-19 era

    Diagnostic and Interventional Radiology, Vol. 27, Núm. 2, pp. 263-268

  2. High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

    Journal of Infection

  3. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

  4. Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies

    Pharmaceutics, Vol. 13, Núm. 7

2020

  1. Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective

    International Journal of Infectious Diseases, Vol. 93, pp. 329-338

  2. Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation

    Pharmaceutics, Vol. 12, Núm. 1

  3. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria

    Anaesthesia Critical Care and Pain Medicine, Vol. 39, Núm. 5, pp. 553-561

2019

  1. ACUsmart continuous renal replacement therapy platform: Multicenter pilot study for technical and clinical assessment (A.M.P. Study)

    Blood Purification, Vol. 48, Núm. 1, pp. 60-66

  2. Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment

    Journal of Critical Care, Vol. 50, pp. 69-76

2018

  1. Percutaneous Transrenal-Ureteral Connection: A New Rendezvous Modification

    Journal of Vascular and Interventional Radiology

  2. Population pharmacokinetics of daptomycin in critically ill patients

    International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165

2016

  1. Mechanical thrombectomy in patients with tumour-related ischaemic stroke

    Interventional Neuroradiology, Vol. 22, Núm. 6, pp. 705-708